Match tier
Listed
Presence
Current · Arkansas
Last published
2025
Sources
OpenAlex · ORCID
Refreshed
2026-10-05
R
Rachel D. Hendrix
Postdoctoral Fellow
Also affiliated: Northern Arizona University (2013); Washington University in St. Louis (2020–2024); University of Arkansas Medical Center (2017); Hope Center for Neurological Disorders (2020–2024)
8 h-index
13 pubs
281 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Rachel D. Hendrix investigates the mechanisms underlying Alzheimer's disease, with a focus on the role of amyloid-beta peptides and their impact on cellular processes. Her work has explored how amyloid precursor protein influences insulin-degrading enzyme levels and how amyloid-beta disrupts glucose transporter localization in astrocytes, potentially affecting brain and blood glucose levels. Hendrix has also examined the potential of pharmacological interventions, such as pimavanserin, to suppress Alzheimer's pathology in mouse models. Her research further extends to the timing of biomarker changes in relation to symptom onset in sporadic Alzheimer's disease and the use of CSF biomarkers to predict cognitive impairment risk in the elderly. Hendrix has published 16 papers, with an h-index of 8 and 282 citations, and collaborates with researchers at the University of Arkansas for Medical Sciences.
Metrics
- h-index: 8
- Publications: 13
- Citations: 281
Positions
-
Postdoctoral Fellow 2018–presentWashington University in St. Louis School of Medicine Neurology ORCID
-
Postdoctoral Fellow publications 2017–2025University of Arkansas for Medical Sciences ORCID
Selected Publications
-
Isotretinoin Use During Consolidation in Acute Promyelocytic Leukemia Following Standard All-Trans Retinoic Acid (ATRA)-Based Induction: A Case Report (2026)
-
Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature (2025)
-
Intranasal Corticosteroid Use and Risk of Invasive Fungal Sinusitis in Acute Myeloid Leukemia, Myelodysplastic Syndrome and Post Transplant Patients (2024)
-
Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues (2018)
-
Functional assessments through novel proteomics approaches: Application to insulin/IGF signaling in neurodegenerative disease' (2018)
Collaboration Network
Top Collaborators
Steven W. Barger
Central Arkansas Veterans Healthcare System
2 shared publications
In database
- Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues
- Functional assessments through novel proteomics approaches: Application to insulin/IGF signaling in neurodegenerative disease'
Anushareddy Muddasani
University of Arkansas for Medical Sciences
2 shared publications
In database
- Intranasal Corticosteroid Use and Risk of Invasive Fungal Sinusitis in Acute Myeloid Leukemia, Myelodysplastic Syndrome and Post Transplant Patients
- Isotretinoin Use During Consolidation in Acute Promyelocytic Leukemia Following Standard All-Trans Retinoic Acid (ATRA)-Based Induction: A Case Report
Sruthi Vellanki
Willis-Knighton Cancer Center
2 shared publications
In database
- Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature
- Navigating Hyperhemolysis in Sickle Cell Disease: Insights from Literature
Srinivas Ayyadevara
Central Arkansas Veterans Healthcare System
1 shared publication
In database
- Functional assessments through novel proteomics approaches: Application to insulin/IGF signaling in neurodegenerative disease'
Akshatha Ganne
University of Arkansas for Medical Sciences
1 shared publication
In database
- Functional assessments through novel proteomics approaches: Application to insulin/IGF signaling in neurodegenerative disease'
Meenakshisundaram Balasubramaniam
University of Arkansas for Medical Sciences
1 shared publication
In database
- Functional assessments through novel proteomics approaches: Application to insulin/IGF signaling in neurodegenerative disease'
Robert J. Shmookler Reis
Central Arkansas Veterans Healthcare System
1 shared publication
In database
- Functional assessments through novel proteomics approaches: Application to insulin/IGF signaling in neurodegenerative disease'
Joshua A. Kulas
University of North Dakota (US)
1 shared publication
- Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues
Whitney Franklin
The University of Texas Medical Branch at Galveston (US)
1 shared publication
- Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues
Nicholas A. Smith
University of North Dakota (US)
1 shared publication
- Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues
Gunjan D. Manocha
University of North Dakota (US)
1 shared publication
- Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues
Kendra L. Puig
University of North Dakota (US)
1 shared publication
- Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues
Kumi Nagamoto‐Combs
University of North Dakota (US)
1 shared publication
- Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues
Giulio Taglialatela
The University of Texas Medical Branch at Galveston (US)
1 shared publication
- Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues
Colin K. Combs
University of North Dakota (US)
1 shared publication
- Ablation of amyloid precursor protein increases insulin-degrading enzyme levels and activity in brain and peripheral tissues
Similar Researchers
Based on overlapping research topics
Jin Hee Sung
University of Arkansas for Medical Sciences
Alzheimer's disease research and treatments
Disease Mechanisms Research
Animal, Disease Models
Zhen He
National Center for Toxicological Research
Disease Mechanisms Research
Neuroscience and Neuropharmacology Research
Animal, Disease Models
Sara M. Venier
University of Arkansas at Fayetteville
Disease Mechanisms Research
Neuroscience and Neuropharmacology Research
Animal, Disease Models
Fabio Ntagwabira
University of Arkansas for Medical Sciences
Dementia and Cognitive Impairment Research
Neuroscience and Neuropharmacology Research
Animal, Disease Models
Akshatha Ganne
University of Arkansas for Medical Sciences
Dementia and Cognitive Impairment Research
Disease Mechanisms Research
Neuroscience and Neuropharmacology Research
Meenakshisundaram Balasubramaniam
University of Arkansas for Medical Sciences
Alzheimer's disease research and treatments
Disease Mechanisms Research
Neuroscience and Neuropharmacology Research